Stefan Bittner Selected Research

Antibodies

1/2024	Early Neuroaxonal Damage in Neurologic Disorders Associated With GAD65 Antibodies.
12/2023	IL-17 receptor goes solo in autoimmune inflammation.
1/2021	Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABAA receptor encephalitis.
1/2020	Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis.
9/2018	GFAPα IgG-associated encephalitis upon daclizumab treatment of MS.
6/2014	Blocking of α4 integrin does not protect from acute ischemic stroke in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan Bittner Research Topics

Disease

53	Multiple Sclerosis 04/2024 - 09/2008
18	Inflammation (Inflammations) 12/2023 - 09/2008
15	Neuroinflammatory Diseases 04/2024 - 04/2010
15	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2018 - 09/2008
12	Stroke (Strokes) 03/2024 - 01/2009
11	Relapsing-Remitting Multiple Sclerosis 09/2023 - 04/2010
7	Disease Progression 03/2024 - 09/2008
5	Ischemic Stroke 09/2023 - 06/2014
4	Infections 03/2024 - 12/2019
4	Nervous System Diseases (Neurological Disorders) 01/2024 - 01/2020
4	Central Nervous System Diseases (CNS Diseases) 10/2023 - 09/2009
4	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 07/2013
4	Leukocytosis (Pleocytosis) 06/2020 - 09/2018
3	COVID-19 01/2024 - 01/2021
3	Neoplasms (Cancer) 01/2023 - 09/2013
3	Ischemia 11/2021 - 12/2013
3	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 10/2013
3	Atrophy 01/2019 - 01/2019
3	Brain Ischemia (Cerebral Ischemia) 12/2013 - 01/2010
2	Central Nervous System Vasculitis 03/2024 - 09/2018
2	Lymphopenia (Lymphocytopenia) 03/2024 - 01/2021
2	Small Fiber Neuropathy 02/2024 - 01/2024
2	Autoimmune Diseases (Autoimmune Disease) 12/2023 - 01/2023
2	Hepatic Encephalopathy 04/2023 - 10/2021
2	Autoimmune Diseases of the Nervous System 01/2021 - 01/2021
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 01/2020
2	Encephalomyelitis (Myeloencephalitis) 06/2020 - 07/2014
2	Polymyositis 12/2015 - 03/2015
2	Rheumatoid Arthritis 07/2015 - 02/2011
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2014 - 01/2009
1	Frontotemporal Dementia With Motor Neuron Disease 01/2024
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2024
1	Alzheimer Disease (Alzheimer's Disease) 01/2024
1	Parkinson Disease (Parkinson's Disease) 01/2024
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2024
1	Agammaglobulinemia (Hypogammaglobulinemia) 06/2023
1	Fibrosis (Cirrhosis) 04/2023
1	End Stage Liver Disease 04/2023
1	Epstein-Barr Virus Infections 01/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Fatigue 01/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022

Drug/Important Bio-Agent (IBA)

22	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2019
12	Potassium Channels (Potassium Channel)IBA 01/2022 - 05/2008
6	AntibodiesIBA 01/2024 - 06/2014
5	Glial Fibrillary Acidic ProteinIBA 04/2024 - 09/2018
5	Alemtuzumab (Campath)FDA Link 01/2022 - 03/2015
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2008
4	ocrelizumabIBA 06/2023 - 01/2021
4	Immunoglobulin G (IgG)IBA 01/2023 - 09/2018
4	Natalizumab (Tysabri)FDA Link 01/2022 - 02/2011
4	Glutamic Acid (Glutamate)FDA Link 01/2022 - 09/2008
4	Dimethyl FumarateIBA 11/2021 - 01/2018
4	CytokinesIBA 01/2021 - 12/2010
4	Myelin-Oligodendrocyte GlycoproteinIBA 04/2014 - 02/2010
3	Ion Channels (Ion Channel)IBA 01/2023 - 12/2011
3	GadoliniumIBA 01/2023 - 06/2020
3	Neuroprotective AgentsIBA 01/2018 - 11/2014
3	Peptides (Polypeptides)IBA 07/2014 - 12/2012
2	Indicators and Reagents (Reagents)IBA 03/2024 - 01/2017
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2024 - 01/2021
2	Immunoglobulin A (IgA)IBA 06/2023 - 01/2019
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2023 - 07/2022
2	SteroidsIBA 09/2022 - 09/2018
2	Tryptophan (L-Tryptophan)FDA Link 09/2022 - 01/2021
2	PotassiumIBA 11/2021 - 12/2013
2	Calcium Channels (Calcium Channel)IBA 11/2021 - 01/2018
2	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 01/2018
2	Interleukin-4 (Interleukin 4)IBA 01/2021 - 01/2018
2	Oligoclonal BandsIBA 06/2020 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2016 - 12/2015
2	Monoclonal AntibodiesIBA 07/2015 - 06/2014
2	AcidsIBA 09/2009 - 05/2008
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 04/2024
1	InterferonsIBA 03/2024
1	Sphingosine-1-Phosphate ReceptorsIBA 03/2024
1	SilverIBA 02/2024
1	Interleukin-17 ReceptorsIBA 12/2023
1	Fingolimod Hydrochloride (FTY720)FDA Link 09/2023
1	Immunoglobulin M (IgM)IBA 06/2023
1	Immunoglobulins (Immunoglobulin)IBA 06/2023
1	AmmoniaIBA 04/2023
1	Interleukin-6 (Interleukin 6)IBA 04/2023
1	Vitamin D FDA LinkGeneric 01/2023
1	dabrafenibIBA 01/2023
1	trametinibIBA 01/2023
1	Amylases FDA Link 01/2023
1	Trypsin InhibitorsIBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	Interleukin-10 (Interleukin 10)IBA 12/2022
1	Methylprednisolone FDA LinkGeneric 09/2022
1	CalciumIBA 01/2022
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2022
1	Dextran SulfateIBA 01/2022
1	EnzymesIBA 01/2022

Therapy/Procedure

24	Therapeutics 03/2024 - 09/2009
3	Immunotherapy 01/2021 - 06/2009
2	Aftercare (After-Treatment) 01/2023 - 01/2020
2	Immunomodulation 01/2023 - 01/2019
1	Thrombectomy 09/2023